Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma
High-grade neuroblastoma (HG-NB) exhibits a significantly diminished survival rate in comparison to low-grade neuroblastoma (LG-NB), primarily attributed to the mechanism of HG-NB is unclear and the lacking effective therapeutic targets and diagnostic model. Therefore, the current investigation aims...
Main Authors: | Wancun Zhang, Mengxin Zhang, Meng Sun, Minghui Hu, Muchun Yu, Jushan Sun, Xianwei Zhang, Bang Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1345734/full |
Similar Items
-
Plasma circulating cell‐free MYCN gene: A noninvasive and prominent recurrence monitoring indicator of neuroblastoma
by: Ying Liang, et al.
Published: (2023-02-01) -
Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma
by: Bang Du, et al.
Published: (2023-10-01) -
A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
by: Mengxin Zhang, et al.
Published: (2022-11-01) -
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
by: Shaohui Huang, et al.
Published: (2022-04-01) -
Epigenetic Dysregulation in <i>MYCN</i>-Amplified Neuroblastoma
by: Soraya Epp, et al.
Published: (2023-12-01)